Panobinostat Biological Correlates Study

NCT01658241 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Nodal Lymphoma
Lymphoma With Cutaneous Involvement
Lymphoma in Leukemic Phase
Marrow Involvement With Lymphoma
Multiple Myeloma

Interventions

DRUG: panobinostat

Sponsor

Peter MacCallum Cancer Centre, Australia